StockpollyBeta
Get App
Popularity #3,970
ACET · NASDAQ · Biotechnology

Adicet Bio (ACET)

Develops off-the-shelf gamma delta CAR-T cell therapies for autoimmune disease and cancer.

$9.10
After hours+0.01 (+0.11%)
At close$9.09(+1.79%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Cost of revenue002000000010
Gross profit00−20000000−10
523229333331303228322022
Research & development262524262623232823251718
775777745744
Selling & marketing00−2000000000
General & administrative777777745744
Other expenses19000000000−10
Operating income−52−32−31−33−33−31−30−32−28−32−22−22
223332211111
Interest income323332211211
Interest expense000000000000
Other non-operating income−2−2−3−3−3−2−2−1−1−1−1−1
Income before tax−50−29−28−30−30−29−28−31−27−31−20−21
Income tax expense000000000000
Net income from continuing operations−50−29−28−30−30−29−28−31−27−31−20−21
Net income−50−29−28−30−30−29−28−31−27−31−20−21
EPS, basic−$18.56−$11.04−$5.60−$5.28−$5.44−$5.12−$4.96−$5.44−$4.64−$2.94−$1.88−$1.99
EPS, diluted−$18.56−$11.04−$5.60−$5.28−$5.44−$5.12−$4.96−$5.44−$4.64−$2.94−$1.88−$1.99
Weighted average shares, basic33566566671111
Weighted average shares, diluted33566566671111
EBITDA−48−28−26−28−29−27−27−30−25−29−19−19
Depreciation & amortization222222222113
EBIT−50−29−28−30−30−29−28−31−27−30−20−21